This inventor holds 1 USPTO granted patent. Top assignee: Development Center for Biotechnology. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Tzu-Yin Lin: Innovator in Cancer Treatment
Introduction
Tzu-Yin Lin is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies for cancer treatment. His innovative work has the potential to impact cancer therapies significantly.
Latest Patents
Tzu-Yin Lin holds a patent for "Humanized antibodies against Globo H and uses thereof in cancer treatments." This patent describes a humanized anti-Globo H antibody, or an scFv or Fab fragment thereof, which includes specific sequences for heavy-chain and light-chain variable domains. The sequences outlined in the patent are crucial for the antibody's functionality in targeting cancer cells.
Career Highlights
Lin is associated with the Development Center for Biotechnology, where he has been instrumental in advancing research in antibody development. His work focuses on creating effective treatments that can improve patient outcomes in cancer therapy.
Collaborations
Tzu-Yin Lin collaborates with notable colleagues, including Chia-Cheng Wu and Szu-Liang Lai. Their combined expertise enhances the research and development efforts at the Development Center for Biotechnology.
Conclusion
Tzu-Yin Lin's contributions to the field of biotechnology, particularly through his patent on humanized antibodies, showcase his commitment to advancing cancer treatment. His work exemplifies the innovative spirit necessary for breakthroughs in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile